| Literature DB >> 36176278 |
Avinash Soundararajan1, Ting Wang1,2, Rekha Sundararajan1, Aruna Wijeratne3,4, Amber Mosley3,4,5, Faith Christine Harvey6,7, Sanjoy Bhattacharya6,7, Padmanabhan Paranji Pattabiraman1,2,3.
Abstract
Trabecular meshwork (TM) tissue is subjected to constant mechanical stress due to the ocular pulse created by the cardiac cycle. This brings about alterations in the membrane lipids and associated cell-cell adhesion and cell-extracellular matrix (ECM) interactions, triggering intracellular signaling responses to counter mechanical insults. A loss of such response can lead to elevated intraocular pressure (IOP), a major risk factor for primary open-angle glaucoma. This study is aimed to understand the changes in signaling responses by TM subjected to mechanical stretch. We utilized multiomics to perform an unbiased mRNA sequencing to identify changes in transcripts, mass spectrometry- (MS-) based quantitative proteomics for protein changes, and multiple reaction monitoring (MRM) profiling-based MS and high-performance liquid chromatography (HPLC-) based MS to characterize the lipid changes. We performed pathway analysis to obtain an integrated map of TM response to mechanical stretch. The human TM cells subjected to mechanical stretch demonstrated an upregulation of protein quality control, oxidative damage response, pro-autophagic signal, induction of anti-apoptotic, and survival signaling. We propose that mechanical stretch-induced lipid signaling via increased ceramide and sphingomyelin potentially contributes to increased TM stiffness through actin-cytoskeleton reorganization and profibrotic response. Interestingly, increased phospholipids and diacylglycerol due to mechanical stretch potentially enable cell membrane remodeling and changes in signaling pathways to alter cellular contractility. Overall, we propose the mechanistic interplay of macromolecules to bring about a concerted cellular response in TM cells to achieve mechanotransduction and IOP regulation when TM cells undergo mechanical stretch.Entities:
Keywords: cytoskeleton; extracellular matrix; glaucoma; lipid signaling; mechanical stretch; multiomics analysis; ocular hypertension; trabecular meshwork (TM)
Year: 2022 PMID: 36176278 PMCID: PMC9513235 DOI: 10.3389/fcell.2022.874828
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
FIGURE 1Transcriptomics analysis of RNA-seq data. (A) Volcano plot of all genes significantly regulated by cyclic mechanical stress. (B) Heatmaps of the top 20 upregulated (left) and top 20 downregulated (right) transcripts abundances based on Log2 FPKM (fragments per kilobase of transcript per million mapped reads). (C) PCA on the correlation matrix (left), scree plot representing the eigenvalues and the proportion of variance accounted for by the principal components (middle), and 2D PCA loading plots for the top 2 (PC1 and PC2) components (right).
Top 20 upregulated genes.
| Gene symbol | Description | Fold change | log2FC |
|
|---|---|---|---|---|
| MSH4 | mutS homolog 4 | 5.827 | 2.543 | 4.8E-10 |
| SLC8A2 | Solute carrier family 8 member A2 | 4.425 | 2.146 | 4.5E-05 |
| AADACP1 | Arylacetamide deacetylase pseudogene 1 | 4.347 | 2.120 | 2.1E-06 |
| C9orf152 | Chromosome 9 open reading frame 152 | 4.081 | 2.029 | 2.0E-04 |
| HSPE1-MOB4 | HSPE1-MOB4 readthrough | 3.702 | 1.888 | 2.8E-05 |
| NRIR | Negative regulator of interferon response | 3.351 | 1.745 | 3.6E-07 |
| C11orf94 | Chromosome 11 open reading frame 94 | 3.059 | 1.613 | 7.6E-05 |
| HIST1H1E | H1.4 Linker Histone, cluster member | 3.022 | 1.595 | 2.3E-05 |
| ATP6V1C2 | ATPase H+ transporting V1 subunit C2 | 2.955 | 1.563 | 1.1E-04 |
| SLCO4A1 | Solute carrier organic anion transporter family member 4A1 | 2.940 | 1.556 | 4.9E-11 |
| SPTBN5 | Spectrin beta, non-erythrocytic 5 | 2.637 | 1.399 | 6.1E-06 |
| FBXW10 | F-box and WD repeat domain containing 10 | 2.618 | 1.389 | 2.4E-05 |
| HRK | Harakiri, BCL2 interacting protein | 2.609 | 1.383 | 7.1E-04 |
| LSMEM1 | Leucine rich single-pass membrane protein 1 | 2.560 | 1.356 | 2.0E-05 |
| LOC284344 | Uncharacterized LOC284344 | 2.497 | 1.320 | 1.2E-04 |
| SLCO5A1 | Solute carrier organic anion transporter family member 5A1 | 2.444 | 1.289 | 8.0E-06 |
| FAM222A | Family with sequence similarity 222 member A | 2.424 | 1.277 | 3.0E-04 |
| C9 | Complement C9 | 2.387 | 1.255 | 3.3E-04 |
| NPPA-AS1 | NPPA antisense RNA 1 | 2.379 | 1.250 | 2.8E-04 |
| LOC100130705 | ATP6V1F neighbor | 2.338 | 1.225 | 3.9E-08 |
Top 20 genes significantly upregulated in TM subjected to CMS with FDR < 6% and log2FC ≥ 0.3. Columns (left to right) show the gene symbol, gene description, fold change, log2FC determined by mRNA sequencing analysis, and calculated p-value, where p < 0.050 was statistically significant.
Pathway enrichment analysis for upregulated genes using ShinyGO based on molecular function.
| Pathway | Genes |
|---|---|
| Active and secondary ion transmembrane transporter activity | SLCO4A1 SLC8A2 SLCO5A1 SLC33A1 SLC5A3 SLC38A2 SLC6A9 |
| Organic anion transmembrane transporter activity | SLCO4A1 SLC38A2 SLCO5A1 ABCC5 SLC33A1 SLC6A9 |
| Neutral amino acid:sodium symporter activity | SLC38A2 SLC6A9 |
| Ubiquitin protein ligase binding | TRAF1 HSPA1B TRIB1 RALA HEL-S-89n DNAJA1 SMAD7 FZD4 FZD8 |
| Heat shock protein binding | HSPA5 DNAJB1 HSPA1B DNAJA1 DNAJB9 CHORDC1 |
| DNA-binding transcription repressor activity | ZBTB1 ZBTB2 BHLHB2 SKIL JDP2 HES1 E2F7 HEY1 |
| Chaperone binding | DNAJB1 DNAJA1 HES1 DNAJB9 HSPA5 |
| SMAD binding | SMAD7 PMEPA1 SKIL LDLRAD4 |
Columns (left to right) show the pathways and genes involved in the given pathway in TM subjected to CMS, based on molecular function using ShinyGO pathway enrichment analysis.
Top 20 downregulated genes.
| Gene symbol | Description | Fold change | log2FC |
|
|---|---|---|---|---|
| CCDC65 | Coiled-coil domain containing 65 | −3.093 | −1.629 | 1.80E-04 |
| GMNC | Geminin coiled-coil domain containing | −3.023 | −1.596 | 5.371E-05 |
| OXCT1-AS1 | OXCT1 antisense RNA 1 | −2.876 | −1.524 | 2.02E-04 |
| PLIN4 | Perilipin 4 | −2.761 | −1.465 | 0.0003009 |
| LINC01006 | Long intergenic non-protein coding RNA 1006 | −2.691 | −1.428 | 0.0003568 |
| RIPOR2 | RHO family interacting cell polarization regulator 2 | −2.339 | −1.226 | 4.23E-04 |
| HRCT1 | Histidine-rich carboxyl terminus 1 | −2.163 | −1.113 | 0.0007467 |
| LINC00957 | Long intergenic non-protein coding RNA 957 | −2.142 | −1.099 | 5.14E-04 |
| ECHDC3 | Enoyl-CoA hydratase domain containing 3 | −2.079 | −1.056 | 1.24E-07 |
| ESPNL | Espin-like | −1.998 | −0.998 | 0.0001494 |
| FAHD2CP | Fumarylacetoacetate hydrolase domain containing 2C, pseudogene | −1.899 | −0.925 | 1.86E-04 |
| SEMA4G | Semaphorin 4G | −1.892 | −0.920 | 2.50E-05 |
| SLC7A14 | Solute carrier family 7 member 14 | −1.868 | −0.902 | 5.99E-04 |
| USP27X-AS1 | USP27X antisense RNA 1 (head to head) | −1.845 | −0.883 | 0.0001952 |
| SLC16A14 | Solute carrier family 16 member 14 | −1.844 | −0.883 | 1.36E-07 |
| HYAL1 | Hyaluronidase 1 | −1.798 | −0.847 | 9.25E-05 |
| RAP2C-AS1 | RAP2C antisense RNA 1 | −1.752 | −0.809 | 1.94E-05 |
| KRT19 | Keratin 19 | −1.723 | −0.785 | 6.72E-06 |
| SMIM10L2B | Small integral membrane protein 10 like 2B | −1.676 | −0.745 | 0.0002565 |
| CLDN11 | Claudin 11 | −1.667 | −0.737 | 7.94E-07 |
Top 20 genes significantly downregulated in TM subjected to CMS with FDR<6% and log2FC ≤ −0.3. Columns (left to right) show the gene symbol, gene description, fold change, log2FC determined by mRNA sequencing analysis, and calculated p-value, where p < 0.050 was statistically significant.
Pathway enrichment analysis for downregulated genes using ShinyGO based on molecular function.
| Pathway | Genes |
|---|---|
| Beta-Alanine metabolism | ALDH3A1 ALDH3B1 ACADS |
| Histidine metabolism | ALDH3A1 ALDH3B1 |
| Phenylalanine metabolism | ALDH3A1 ALDH3B1 |
| Peroxisome | CRAT IDH2 PEX11B |
| Metabolic pathways | ALDH3A1 ALDH3B1 FECH GCNT1 HYAL1 IDH2 ACADS MPI PLCD1 ETNK2 |
| AGE-RAGE signaling pathway in diabetic complications | PLCD1 CCL2 VCAM1 |
| Tyrosine metabolism | ALDH3A1 ALDH3B1 |
| Fatty acid degradation | CPT2 ACADS |
Columns (left to right) show the pathways and genes involved in the given pathway in TM subjected to CMS, based on molecular function using ShinyGO pathway enrichment analysis.
Top 10 upregulated cellular proteins.
| Gene symbol | Accession | Description | Fold change | log2FC |
|
|---|---|---|---|---|---|
| METTL13 | Q8N6R0 | Methyltransferase-like protein 13 | 1.879 | 0.910 | 0.035 |
| SFSWAP | Q12872 | Splicing factor, suppressor of white-apricot homolog | 1.399 | 0.480 | 0.031 |
| FAM8A1 | Q9UBU6 | Protein FAM8A1 | 1.324 | 0.410 | 0.050 |
| SLC38A2 | Q96QD8 | Sodium-coupled neutral amino acid transporter 2 | 1.308 | 0.390 | 0.038 |
| GATAD2B | Q8WXI9 | Transcriptional repressor p66-beta | 1.312 | 0.390 | 0.018 |
| SNRNP27 | Q8WVK2 | U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein | 1.3 | 0.380 | 0.012 |
| NRBF2 | Q96F24 | Nuclear receptor-binding factor 2 | 1.272 | 0.350 | 0.007 |
| ATXN3 | P54252 | Ataxin-3 | 1.263 | 0.340 | 0.014 |
| FDFT1 | P37268 | Squalene synthase | 1.256 | 0.330 | 0.044 |
| MKL2 | Q9ULH7 | MKL/myocardin-like protein 2 | 1.249 | 0.320 | 0.020 |
Top 10 proteins upregulated in TM subjected to CMS with FDR ≤ 5% and log2FC ≥ 0.3. Columns (left to right) show the gene symbol, UniProt accession number, protein description, fold change, log2FC determined by global proteomic analysis, and calculated p-value, where p < 0.050 was statistically significant.
Pathway enrichment analysis for upregulated cellular proteins using ShinyGO based on molecular function.
| Pathway | Proteins |
|---|---|
| RNA binding | BCLAF1 STAU2 CCAR1 DAZAP1 PUM3 DDX18 FUS PUS7 EIF3D ZC3H14 RBM3 HNRNPUL1 MRPL27 EFTUD2 RPL24 RBM25 G3BP2 EIF3H ZFP36L2 LARP4 RPL29 HNRNPF TMSB4X NELFE DDX3X NAP1L4 HNRNPH1 MRPS18A SFSWAP SMARCE1 PHAX |
| Single-stranded RNA binding | DAZAP1 ZC3H14 LARP4 HNRNPF DDX3X HNRNPH1 |
| Poly-purine tract binding | DAZAP1 ZC3H14 LARP4 DDX3X |
| Nucleic acid binding | BCLAF1 STAU2 CCAR1 DAZAP1 SMARCE1 PUM3 DDX18 FUS PUS7 EIF3D ZC3H14 RBM3 HNRNPUL1 MRPL27 EFTUD2 RPL24 RBM25 G3BP2 EIF3H ZFP36L2 LARP4 RPL29 HNRNPF TMSB4X NELFE DDX3X GATAD2B NAP1L4 HNRNPH1 MRPS18A SMAD3 SFSWAP PHAX SNRNP27 |
| Poly(A) binding | ZC3H14 LARP4 DDX3X |
| Isomerase activity | IDI1 PUS7 GLCE GNE PPIH HMGCS1 |
| Cadherin binding | MICALL1 RPL24 USP8 TMOD3 STX5 RPL29 MRTFB DDX3X |
| Ubiquitin protein ligase binding | GABARAPL2 GABARAPL1 ATXN3 DNAJA1 NDUFS2 SMAD3 DAXX |
| Ubiquitin binding | BUB3 NEDD4 SMAD3 TAB2 |
| Nuclear receptor binding | SMARCE1 FUS SMAD3 DAXX |
| Tat protein binding | DNAJA1 GABARAPL1 |
| RNA polymerase II-specific DNA-binding transcription factor binding | SMARCE1 FUS DNAJA1 GABARAPL1 SMAD3 DAXX |
| RNA stem-loop binding | DDX3X DAZAP1 |
| Transcription coactivator activity | CCAR1 MRTFB FUS DAXX NCOA4 SMARCE1 |
Columns (left to right) show the pathways and proteins involved in the given pathway in TM subjected to CMS, based on molecular function using ShinyGO pathway enrichment analysis.
FIGURE 2Immunoblot analysis for ECM and fibrosis-related proteins and proteins involved in cholesterol biosynthesis. (A) Confirmatory analysis for protein expression changes in HTM cells subjected to CMS for 24 h. COL1A2, total laminin, MKL2, and PAI-1 showed a significant upregulation at 24 h of CMS (ST) compared to unstretched control (CTL). (B) Confirmatory analysis for proteins involved in cholesterol biosynthesis in HTM cells subjected to CMS for 24 h. HMGCS1 and n-SREBP2 showed a significant upregulation at 24 h of CMS (ST) compared to unstretched control (CTL). The results were based on immunoblot analysis with subsequent densitometric analysis. GAPDH was immunoblotted as the loading control. Circles and boxes in the histograms represent sample numbers for CTL and ST, respectively. Values represent mean ± SEM, where n = 4 (biological replicates). *p ≤ 0.050 was considered significant.
Top 20 downregulated cellular proteins.
| Gene symbol | Accession | Description | Fold change | log2FC |
|
|---|---|---|---|---|---|
| CCDC113 | Q9H0I3 | Coiled-coil domain-containing protein 113 | 0.518 | −0.950 | 0.009 |
| CCDC170 | Q8IYT3 | Coiled-coil domain-containing protein 170 | 0.53 | −0.910 | 0.028 |
| RASSF3 | Q86WH2 | Ras association domain-containing protein 3 | 0.556 | −0.850 | 0.042 |
| CASP8AP2 | Q9UKL3 | CASP8-associated protein 2 | 0.585 | −0.770 | 0.035 |
| SYNE2 | Q8WXH0 | Nesprin-2 | 0.588 | −0.770 | 0.037 |
| DOCK2 | Q92608 | Dedicator of cytokinesis protein 2 | 0.59 | −0.760 | 0.026 |
| LRRC7 | Q96NW7 | Leucine-rich repeat-containing protein 7 | 0.643 | −0.640 | 0.023 |
| HYDIN | Q4G0P3 | Hydrocephalus-inducing protein homolog | 0.676 | −0.570 | 0.040 |
| NDE1 | Q9NXR1 | Nuclear distribution protein nudE homolog 1 | 0.681 | −0.550 | 0.016 |
| MYH4 | Q9Y623 | Myosin-4 | 0.682 | −0.550 | 0.017 |
| NRXN3 | Q9Y4C0 | Neurexin-3 | 0.687 | −0.540 | 0.008 |
| ZNF207 | O43670 | BUB3-interacting and GLEBS motif-containing protein ZNF207 | 0.704 | −0.510 | 0.036 |
| KEAP1 | Q14145 | Kelch-like ECH-associated protein 1 | 0.718 | −0.480 | 0.042 |
| CHD8 | Q9HCK8 | Chromodomain-helicase-DNA-binding protein 8 | 0.729 | −0.460 | 0.015 |
| FSHR | P23945 | Follicle-stimulating hormone receptor | 0.747 | −0.420 | 0.022 |
| AP3M2 | P53677 | AP-3 complex subunit mu-2 | 0.755 | −0.410 | 0.040 |
| PMM2 | O15305 | Phosphomannomutase 2 | 0.756 | −0.400 | 0.023 |
| PCBP3 | P57721 | Poly(rC)-binding protein 3 | 0.765 | −0.390 | 0.007 |
| ATG13 | O75143 | Autophagy-related protein 13 | 0.766 | −0.390 | 0.036 |
| TMEM132B | Q14DG7 | Transmembrane protein 132B | 0.766 | −0.380 | 0.035 |
Top 20 proteins significantly downregulated in TM subjected to CMS with FDR ≤ 5% and log2FC ≤ -0.3. Columns (left to right) show the gene symbol, UniProt accession number, protein description, fold change, log2FC determined by global proteomic analysis, and calculated p value, where p < 0.050 was statistically significant.
Pathway enrichment analysis for downregulated cellular proteins using ShinyGO based on molecular function.
| High level GO category | Proteins |
|---|---|
| Regulation of biological quality | GRIPAP1 KEAP1 F10 BDH2 STIM1 DDAH1 FSHR APRT ZNF207 TNIP2 NMT1 |
| Cellular localization | ATG13 GRIPAP1 NDE1 SYNE2 AP3M2 DOCK2 HEL-S-163pA F10 NMT1 APRT |
| Response to stress | F10 UBE4B BRCC3 KEAP1 DDAH1 TFEC TNIP2 ATG13 FSHR |
| Response to external stimulus | CHD8 CMPK2 DOCK2 TNIP2 NRXN3 F10 NMT1 FSHR |
| Regulation of molecular function | KEAP1 STIM1 FSHR PHACTR3 DOCK2 BRCC3 NDE1 DDAH1 |
| Regulation of localization | ATG13 GRIPAP1 STIM1 SYNE2 DOCK2 F10 NMT1 |
| System process | DDAH1 MYH4 CHD8 FSHR NRXN3 STIM1 |
| Catabolic process | UBE4B ATG13 KEAP1 DDAH1 BDH2 PRELP |
| Regulation of signaling | TNIP2 CHD8 F10 FSHR NMT1 STIM1 |
| Cellular component biogenesis | ZNF207 CCDC113 ATG13 NDE1 SYNE2 MRM3 |
| Regulation of multicellular organismal process | COL4A2 KEAP1 DDAH1 FSHR STIM1 F10 |
| Immune system process | DOCK2 FSHR TNIP2 HEL-S-163pA APRT |
Columns (left to right) show the pathways and proteins involved in the given pathway in TM subjected to CMS, based on molecular function using ShinyGO pathway enrichment analysis.
FIGURE 3Cellular lipid analysis. (A) Heatmap of the total cellular phospholipids in control and stretched HTM cells. (B) Heatmap of the total cellular ceramide (Cer) in control and stretched HTM cells. (C) Heatmap of the total cellular cholesteryl ester in control and stretched HTM cells. (D) Heatmap of the total cellular diacylglycerol (DG) in control and stretched HTM cells. (E) Heatmap of the total cellular triglyceride (TAG) in control and stretched HTM cells. All heatmaps are presented by control (left 3 red columns) and stretched HTM cells (right green columns), total n = 3 pairs (biological replicates). Analysis parameters utilized the Ward clustering algorithm, Euclidean distance measure, and autoscaling based upon samples (performed using MetaboAnlayst 5.0). Comparison between control and stretched HTM cells. (F) Total cellular phospholipids were significantly increased in stretched HTM cells. (G) Total cellular phosphatidylcholine (PC) was significantly increased in stretched HTM cells. (H) Total cellular sphingomyelin (SM) was increased in stretched HTM cells but was nonsignificant. (I) Total cellular Cer was significantly increased in stretched HTM cells. (J) Total cellular cholesteryl ester was significantly decreased in stretched HTM cells. (K) Total cellular DG was significantly increased in stretched HTM cells. (L) Total cellular TAG was significantly decreased in stretched HTM cells. Values represent the mean ± SEM, where n = 3 (biological replicates). *p ≤ 0.050 was considered significant.
FIGURE 4Secretory lipid analysis. (A) Heatmap of the total media phospholipids in control and stretched HTM cells. (B) Heatmap of the total media lysophospholipids in control and stretched HTM cells. Comparison between control and stretched HTM cell culture media. (C) Total media phospholipids were increased in stretched HTM cell culture media but were nonsignificant. (D) Total media lysophospholipids were significantly decreased in HTM cell culture media. Values represent the mean ± SEM, where n = 3 (biological replicates). *p ≤ 0.050 was considered significant.
FIGURE 5STRING network analysis of upregulated proteostasis-associated genes and proteins. Colored lines between the nodes indicate their basis for interconnection. Table here gives a list of inclusive genes and proteins. Overall, the protein–protein interaction (PPI) enrichment p-value is shown for connected nodes and is considered significant if p < 0.05 with individual PPI interaction significance not shown.
FIGURE 6STRING network analysis of actin cytoskeleton and ECM-associated genes and proteins. (A) Network analysis of all upregulated actin cytoskeleton and ECM-associated genes and proteins. (B) Network analysis of all downregulated actin cytoskeleton and ECM-associated genes and proteins. Table here gives a list of inclusive genes and proteins. Colored lines between the nodes indicate their basis for interconnection. Overall PPI enrichment p-value is shown for connected nodes and is considered significant if p < 0.05 with individual PPI interaction significance not shown.
FIGURE 7Graphical abstract derived from the multiomics analysis representing the modulation in signaling mechanisms activated and suppressed in TM due to the mechanical (created using BioRender.com).